Abstract
The European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better funded, more focused European hematology research. Initiated by the EHA, around 300 experts contributed to the consensus document, which will help European policy makers, research funders, research organizations, researchers, and patient groups make better informed decisions on hematology research. It also aims to raise public awareness of the burden of blood disorders on European society, which purely in economic terms is estimated at ∈ European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better fu treatments, sometimes in revolutionary ways. This progress highlights the potential of focused basic research programs such as this EHA Roadmap. The EHA Roadmap identifies nine ‘sections’ in hematology: normal hematopoiesis, malignant lymphoid and myeloid diseases, anemias and related diseases, platelet disorders, blood coagulation and hemostatic disorders, transfusion medicine, infections in hematology, and hematopoietic stem cell transplantation. These sections span 60 smaller groups of diseases or disorders. The EHA Roadmap identifies priorities and needs across the field of hematology, including those to develop targeted therapies based on genomic profiling and chemical biology, to eradicate minimal residual malignant disease, and to develop cellular immunotherapies, combination treatments, gene therapies, hematopoietic stem cell treatments, and treatments that are better tolerated by elderly patients.
Original language | English |
---|---|
Pages (from-to) | 115-208 |
Number of pages | 94 |
Journal | Haematologica |
Volume | 101 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 1 2016 |
ASJC Scopus subject areas
- Hematology
Fingerprint
Dive into the research topics of 'The european hematology association roadmap for european hematology research: A consensus document'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
The european hematology association roadmap for european hematology research : A consensus document. / Engert, Andreas; Balduini, Carlo; Brand, A. et al.
In: Haematologica, Vol. 101, No. 2, 01.02.2016, p. 115-208.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - The european hematology association roadmap for european hematology research
T2 - A consensus document
AU - Engert, Andreas
AU - Balduini, Carlo
AU - Brand, A.
AU - Coiffier, Bertrand
AU - Cordonnier, Catherine
AU - Döhner, Hartmut
AU - De Wit, Thom Duyvené
AU - Eichinger, Sabine
AU - Fibbe, W. E.
AU - Green, Tony
AU - De Haas, Fleur
AU - Iolascon, Achille
AU - Jaffredo, Thierry
AU - Rodeghiero, F.
AU - Sall Es, Gilles
AU - Schuringa, Jan Jacob
AU - André, Marc P E
AU - André-Schmutz, Isabelle
AU - Bacigalupo, A.
AU - Bochud, Pierre Yves
AU - Den Boer, Monique L.
AU - Bonini, Chiara
AU - Camaschella, Clara
AU - Cant, Andrew J.
AU - Cappellini, Maria Domenica
AU - Cazzola, Mario
AU - Celso, C. L.
AU - Dimopoulos, M.
AU - Douay, L.
AU - Dzierzak, Elaine
AU - Einsele, Hermann
AU - Ferreri, Andres
AU - De Franceschi, Lucia
AU - Gaulard, P.
AU - Gottgens, Berthold
AU - Greinacher, Andreas
AU - Gresele, Paolo
AU - Gribben, John G.
AU - De Haan, Gerald
AU - Hansen, John Bjarne
AU - Hochhaus, A.
AU - Kadir, Rezan A.
AU - Kaveri, Srinivas
AU - Kouskoff, Valerie
AU - Kühne, Thomas
AU - Kyrle, Paul Alexander
AU - Ljungman, Per
AU - Maschmeyer, G.
AU - Méndez-Ferrer, Simón
AU - Milsom, Michael
AU - Mummery, Christine
AU - Ossenkoppele, Gert J.
AU - Pecci, Alessandro
AU - Peyvandi, Flora
AU - Philipsen, S.
AU - Reitsma, Pieter H.
AU - Ribera, J. M.
AU - Risitano, Antonio
AU - Rivella, Stefano
AU - Ruf, Wolfram
AU - Schroeder, Timm
AU - Scully, M. A.
AU - Sociè, Gerard
AU - Staal, Frank
AU - Stanworth, Simon
AU - Stauder, Reinhard
AU - Stilgenbauer, Stephan
AU - Tamary, H.
AU - Theilgaard-Mönch, Kim
AU - Thein, Swee Lay
AU - Tilly, Hervé
AU - Trneny, M.
AU - Vainchenker, William
AU - Vannucchi, Alessandro M.
AU - Viscoli, Claudio
AU - Vrielink, H.
AU - Zaaijer, Hans
AU - Zanella, Alberto
AU - Zolla, Lello
AU - Zwaginga, J. J.
AU - Martinez, Patricia Aguilar
AU - Van Den Akker, Emile
AU - Allard, Shubha
AU - Anagnou, Nicholas P.
AU - Andolfo, Immacolata
AU - Andrau, Jean Christophe
AU - Angelucci, E.
AU - Anstee, David
AU - Aurer, I.
AU - Avet-Loiseau, Hervé
AU - Aydinok, Yesim
AU - Bakchoul, Tamam
AU - Balduini, A.
AU - Barcellini, Wilma
AU - Baruch, Dominique
AU - Baruchel, André
AU - Bayry, Jagadeesh
AU - Bento, Celeste
AU - van den Berg, Anke
AU - Bernardi, Rosa
AU - Bianchi, Paola
AU - Bigas, Anna
AU - Biondi, A.
AU - Bohonek, Milos
AU - Bonnet, Dominique
AU - Borchmann, Peter
AU - Borregaard, Niels
AU - Braekkan, S. K.
AU - van den Brink, Marcel R M
AU - Brodin, Ellen
AU - Bullinger, Lars
AU - Buske, Christian
AU - Butzeck, Barbara
AU - Cammenga, Jörg
AU - Campo, Elias
AU - Carbone, Antonino
AU - Cervantes, F.
AU - Cesaro, S.
AU - Charbord, Pierre
AU - Claas, F. H J
AU - Cohen, Hannah
AU - Conard, Jacqueline
AU - Coppo, Paul
AU - Vives Corron, Joan Lluis
AU - Da Costa, Lydie
AU - Davi, Frederic
AU - Delwel, Ruud
AU - Dianzani, I.
AU - Domanović, Dragoslav
AU - Donnelly, Peter
AU - Drnovšek, Tadeja Dovč
AU - Dreyling, Martin H.
AU - Du, Ming Qing
AU - Dufour, Carlo
AU - Durand, Charles
AU - Efremov, Dimitar G.
AU - Eleftheriou, Androulla
AU - Elion, Jacques
AU - Emonts, Marieke
AU - Engelhardt, Monika
AU - Ezine, Sophie
AU - Falkenburg, Fred
AU - Favier, Remi
AU - Federico, Massimo
AU - Fenaux, Pierre
AU - Fitzgibbon, Jude
AU - Flygare, Johan
AU - Foà, Robin
AU - Forrester, Lesley
AU - Galacteros, Frederic
AU - Garagiola, Isabella
AU - Gardiner, Chris
AU - Garraud, Olivier
AU - Van Geet, Christel
AU - Geiger, Hartmut
AU - Geissler, J.
AU - Germing, Ulrich
AU - Ghevaert, Cedric
AU - Girelli, Domenico
AU - Godeau, Bertrand
AU - Gökbuget, Nicola
AU - Goldschmidt, Hartmut
AU - Goodeve, A.
AU - Graf, Thomas
AU - Graziadei, Giovanna
AU - Griesshammer, Martin
AU - Gruel, Yves
AU - Guilhot, F.
AU - Von Gunten, Stephan
AU - Gyssens, I. C.
AU - Halter, Joerg P.
AU - Harrison, Claire N.
AU - Harteveld, Cornelis L.
AU - Hellström-Lindberg, Eva
AU - Hermine, Olivier
AU - Higgs, Douglas
AU - Hillmen, Peter
AU - Hirsch, H. H.
AU - Hoskin, P.
AU - Huls, Gerwin
AU - Inati, A.
AU - Johnson, Peter
AU - Kattamis, Antonis
AU - Kiefel, V.
AU - Kleanthous, Marina
AU - Klump, Hannes
AU - Krause, Daniela
AU - Hovinga, Johanna Kremer
AU - Lacaud, Georges
AU - Lacroix-Desmazes, S.
AU - Landman-Parker, Judith
AU - LeGouill, Steven
AU - Lenz, Georg
AU - Von Lilienfeld-Toal, M.
AU - von Lindern, M.
AU - López-Guillermo, Armando
AU - Lopriore, Enrico
AU - Lozano, M.
AU - Macintyre, Elizabeth
AU - Makris, Michael
AU - Mannhalter, C.
AU - Martens, Joost H A
AU - Mathas, Stephan
AU - Matzdorff, Axel
AU - Medvinsky, Alexander
AU - Menendez, Pablo
AU - Migliaccio, A. R.
AU - Miharada, Kenichi
AU - Mikulska, Malgorzata
AU - Minard, Véronique
AU - Montalbán, Carlos
AU - De Montalembert, Mariane
AU - Montserrat, Emili
AU - Morange, P. E.
AU - Mountford, Joanne
AU - Muckenthaler, Martina
AU - Müller-Tidow, Carsten
AU - Mumford, Andrew
AU - Nadel, Bertrand
AU - Navarro, José Tomás
AU - El Nemer, Wassim
AU - Noizat-Pirenne, France
AU - O’Mahony, Brian
AU - Oldenburg, J.
AU - Olsson, Martin
AU - Oostendorp, Robert
AU - Palumbo, A.
AU - Passamonti, Francesco
AU - Patient, Roger
AU - de Latour, Regis Peffault
AU - Pflumio, Francoise
AU - Pierelli, L.
AU - Piga, Antonio
AU - Pollard, D.
AU - Raaijmakers, Marc
AU - Radford, J.
AU - Rambach, Ralf
AU - Koneti Rao, A.
AU - Raslova, Hana
AU - Rebulla, Paolo
AU - Rees, David C.
AU - Ribrag, Vincent
AU - Rijneveld, Anita
AU - Rinalducci, Sara
AU - Robak, Tadeusz
AU - Roberts, I.
AU - Rodrigues, Charlene
AU - Rosendaal, F. R.
AU - Rosenwald, Andreas
AU - Rule, S.
AU - Russo, Roberta
AU - Saglio, G.
AU - Sanchez, Mayka
AU - Scharf, R. E.
AU - Schlenke, Peter
AU - Semple, John
AU - Sierra, Jorge
AU - So-Osman, Cynthia
AU - Soria, José Manuel
AU - Stamatopoulos, Kostas
AU - Stegmayr, Bernd
AU - Stunnenberg, Hendrik G.
AU - Swinkels, Dorine W.
AU - Barata, João Pedro Taborda
AU - Taghon, Tom
AU - Taher, Ali T.
AU - Terpos, Evangelos
AU - Thachil, Jecko
AU - Tissot, Jean Daniel
AU - Touw, Ivo P.
AU - Toye, Ash
AU - Trappe, Ralf
AU - Traverse-Glehen, A.
AU - Unal, Sule
AU - Vaulont, Sophie
AU - Viprakasit, Vip
AU - Vitolo, U.
AU - Van Wijk, R.
AU - Wójtowicz, Agnieszka
AU - Zeerleder, Sacha
AU - Zieger, Barbara
PY - 2016/2/1
Y1 - 2016/2/1
N2 - The European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better funded, more focused European hematology research. Initiated by the EHA, around 300 experts contributed to the consensus document, which will help European policy makers, research funders, research organizations, researchers, and patient groups make better informed decisions on hematology research. It also aims to raise public awareness of the burden of blood disorders on European society, which purely in economic terms is estimated at ∈ European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better fu treatments, sometimes in revolutionary ways. This progress highlights the potential of focused basic research programs such as this EHA Roadmap. The EHA Roadmap identifies nine ‘sections’ in hematology: normal hematopoiesis, malignant lymphoid and myeloid diseases, anemias and related diseases, platelet disorders, blood coagulation and hemostatic disorders, transfusion medicine, infections in hematology, and hematopoietic stem cell transplantation. These sections span 60 smaller groups of diseases or disorders. The EHA Roadmap identifies priorities and needs across the field of hematology, including those to develop targeted therapies based on genomic profiling and chemical biology, to eradicate minimal residual malignant disease, and to develop cellular immunotherapies, combination treatments, gene therapies, hematopoietic stem cell treatments, and treatments that are better tolerated by elderly patients.
AB - The European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better funded, more focused European hematology research. Initiated by the EHA, around 300 experts contributed to the consensus document, which will help European policy makers, research funders, research organizations, researchers, and patient groups make better informed decisions on hematology research. It also aims to raise public awareness of the burden of blood disorders on European society, which purely in economic terms is estimated at ∈ European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better fu treatments, sometimes in revolutionary ways. This progress highlights the potential of focused basic research programs such as this EHA Roadmap. The EHA Roadmap identifies nine ‘sections’ in hematology: normal hematopoiesis, malignant lymphoid and myeloid diseases, anemias and related diseases, platelet disorders, blood coagulation and hemostatic disorders, transfusion medicine, infections in hematology, and hematopoietic stem cell transplantation. These sections span 60 smaller groups of diseases or disorders. The EHA Roadmap identifies priorities and needs across the field of hematology, including those to develop targeted therapies based on genomic profiling and chemical biology, to eradicate minimal residual malignant disease, and to develop cellular immunotherapies, combination treatments, gene therapies, hematopoietic stem cell treatments, and treatments that are better tolerated by elderly patients.
UR - http://www.scopus.com/inward/record.url?scp=84981361090&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84981361090&partnerID=8YFLogxK
U2 - 10.3324/haematol.2015.136739
DO - 10.3324/haematol.2015.136739
M3 - Article
VL - 101
SP - 115
EP - 208
JO - Haematologica
JF - Haematologica
SN - 0390-6078
IS - 2
ER -